Impact of Targeted Therapy on Cancer-Related Cognitive Impairment
Abroad (travel likely)Recruiting
Conditions
Disease/Condition Name Cancer-related Cognitive Dysfunction · Chronic Lymphocytic Leukemia (CLL) · Chronic Myeloid Leukemia, BCR-ABL1 Positive
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Rochester NCORP Research Base, Rochester, New York, United States
Contact: Principal Investigator (Karen Mustian, PhD)
Study leads
Michelle Janelsins, PhD
Study Chair
University of Rochester NCORP Research Base